Balla, Zsuzsanna http://orcid.org/0000-0002-9041-5036
Ignácz, Bettina
Varga, Lilian http://orcid.org/0000-0002-5484-364X
Kőhalmi, Kinga Viktória http://orcid.org/0000-0002-7381-6866
Farkas, Henriette http://orcid.org/0000-0003-2929-1721
Funding for this research was provided by:
OTKA (National Research, Development and Innovation Office grant N° K124557.)
Semmelweis University
Article History
Accepted: 5 February 2021
First Online: 3 March 2021
Declarations
:
: The study protocol was approved by the institutional review board of Semmelweis University of Budapest. Informed consent was obtained from the participants in accordance with the Declaration of Helsinki.
: HF, KCK, and ZB designed the study. BI collected and extracted the data, KVK, LV, and ZB participated in the study protocol for the data analysis. ZB performed the analyses and prepared the first draft of the manuscript.
: KVK—has received honoraria and travel grants from CSL Behring and Shire and has participated in clinical trials of BioCryst, CSL Behring, Pharming and Shire.LV—has received travel grants from CSL Behring and Shire Human Genetic Therapies Inc.HF—received research grants from CSL Behring, Shire/Takeda and Pharming and served as an advisor for these companies and Biocryst, and has participated in clinical trials/registries for BioCryst, CSL Behring, Pharming, Kalvista and Shire/Takeda. The other authors have declared that no conflict of interest exists.